Search - tctmd.com

Displaying 61 - 80 of 99

Sort: Relevancy | Date

News Conference News TCT 2017

MAVERIC: Transcatheter MV Repair Shows Continued Efficacy, Safety at 6 Months

TCT Daily Staff

November 06, 2017

News Conference News TCT 2017

For ‘Torrential’ Tricuspid Regurgitation, Two New Transcatheter Devices Safe, Effective in Early Results

Yael L. Maxwell

November 02, 2017

News Conference News TCT 2017

TRACER: Novel Device Effective in Reducing Severe Degenerative MR Over 6 Months

Yael L. Maxwell

November 01, 2017

News Conference News TCT 2017

3-D Printing Opportunities Emerge for Cardiologists, Hospitals, and Device Companies Alike

Yael L. Maxwell

October 31, 2017

Presentation TCT 2017

A Conceptual Framework for Selection of MR Patients for Medical Therapy, Surgery, and Transcatheter Therapies

Presenter: Paul A. Grayburn, Maurice E. Sarano, Allan Schwartz

October 30, 2017

Presentation TCT 2016

TCT 1033: An Iatrogenic Circumflex Coronary Occlusion Post-Mitral Valve Surgery: Procedural and Management Considerations

Presenter: Emmanouil S. Brilakis, Ricardo A. Costa, Po Fun Chan

October 31, 2016

Presentation TCT 2015

MV Surgery After MitraClip: Whats Possible and Whats Not

Presenter: Stephan Baldus, Saibal Kar, Alfredo Trento

October 14, 2015

Presentation TCT 2015

Debate: Two+ MR After Transcatheter MV Repair as a Failed Procedure Weve Learned This From Surgery!

Presenter: Stephan Baldus, Saibal Kar, Joerg Seeburger

October 14, 2015

Presentation TCT 2015

Implications of Tricuspid Regurgitation and/or Severe Pulmonary Hypertension in Patients Undergoing MV Surgery or MitraClip

Presenter: Stephan Baldus, Saibal Kar, Jason H. Rogers

October 14, 2015

News Conference News TCT 2015

Percutaneous Paravalvular Leak Closure in Failed Surgical Valves Feasible

October 14, 2015

News Conference News TCT 2015

Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored

October 13, 2015

News Conference News TCT 2015

Companies With Innovative Technologies Compete in TCT Shark Tank

October 13, 2015

News Conference News TCT 2015

Experts Debate Mitral Valve Repair, Replacement for Intermediate-Risk Patients

October 12, 2015

Presentation TCT 2015

Examples of Cases Where MV Surgery for MR Failed (and Reasons Why)

Presenter: Khalil Fattouch, James B. Hermiller Jr, Vinayak Bapat

October 11, 2015

Presentation TCT 2015

I Performed Surgery in This Intermediate-Risk Patient With Isolated Secondary MR With These Results: Does the Panel Agree?

Presenter: Khalil Fattouch, James B. Hermiller Jr, Thomas Walther

October 11, 2015

Presentation TCT 2015

Debate: The Intermediate Surgical Risk Patient With P2 Prolapse The Case for MV Surgery!

Presenter: Khalil Fattouch, James B. Hermiller Jr, Michael Argenziano

October 11, 2015

Presentation TCT 2015

The Real-World Practice of Surgery in Primary and Secondary MR: European Insights

Presenter: Michael J. Mack, Patrick M. McCarthy, Ruediger Lange

October 11, 2015

Presentation TCT 2015

The Real-World Practice of Surgery in Primary and Secondary MR: Outcomes in the Medicare Population

Presenter: Michael J. Mack, Patrick M. McCarthy, Christina Vassileva

October 11, 2015

News Features TCT 2014

Thoughtful Insights at TCT: Many Questions Remain Around Treatment of Valvular Disease

Todd Neale

October 24, 2014

News Conference News TCT 2014

Views Differ on Future of Percutaneous Mitral Valve Therapies

September 16, 2014

Advertisement

MAVERIC: Transcatheter MV Repair Shows Continued Efficacy, Safety at 6 Months

For ‘Torrential’ Tricuspid Regurgitation, Two New Transcatheter Devices Safe, Effective in Early Results

TRACER: Novel Device Effective in Reducing Severe Degenerative MR Over 6 Months

3-D Printing Opportunities Emerge for Cardiologists, Hospitals, and Device Companies Alike

A Conceptual Framework for Selection of MR Patients for Medical Therapy, Surgery, and Transcatheter Therapies

TCT 1033: An Iatrogenic Circumflex Coronary Occlusion Post-Mitral Valve Surgery: Procedural and Management Considerations

MV Surgery After MitraClip: Whats Possible and Whats Not

Debate: Two+ MR After Transcatheter MV Repair as a Failed Procedure Weve Learned This From Surgery!

Implications of Tricuspid Regurgitation and/or Severe Pulmonary Hypertension in Patients Undergoing MV Surgery or MitraClip

Percutaneous Paravalvular Leak Closure in Failed Surgical Valves Feasible

Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored

Companies With Innovative Technologies Compete in TCT Shark Tank

Experts Debate Mitral Valve Repair, Replacement for Intermediate-Risk Patients

Examples of Cases Where MV Surgery for MR Failed (and Reasons Why)

I Performed Surgery in This Intermediate-Risk Patient With Isolated Secondary MR With These Results: Does the Panel Agree?

Debate: The Intermediate Surgical Risk Patient With P2 Prolapse The Case for MV Surgery!

The Real-World Practice of Surgery in Primary and Secondary MR: European Insights

The Real-World Practice of Surgery in Primary and Secondary MR: Outcomes in the Medicare Population

Thoughtful Insights at TCT: Many Questions Remain Around Treatment of Valvular Disease

Views Differ on Future of Percutaneous Mitral Valve Therapies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content